Possible Drug-Associated Sialolithiasis by the Bicarbonate Anhydrase Inhibitor Topiramate: A Case Report and Literature Review

Publication date: Available online 20 May 2016
Source:Journal of Oral and Maxillofacial Surgery
Author(s): Amber V.K. Buhler, Pearl Huynh, Pauline Low, Mary Von
Topiramate is an antiepileptic drug indicated for the treatment of seizure disorders, migraine prophylaxis, and more recently, for weight loss. This new indication will likely increase use of this agent significantly. As a carbonic anhydrase inhibitor, topiramate can affect the pH of bodily fluids, and is known to increase risk of nephrolithiasis. However, as discussed here, these properties also result in an as so far unaddressed risk for development of sialoliths, calcified stones formed in the salivary duct or glands. The physiological mechanisms for stone development in the salivary gland are reviewed, and the pharmacological effects of topiramate on sialolith formation are discussed. This report describes a female patient treated with topiramate for migraine prophylaxis who subsequently presented with a sialolith in the left submandibular duct.



from #ENT via xlomafota13 on Inoreader http://ift.tt/1TuCYg7
via IFTTT